General Fusion (GFUZ) Stock Performance – 24‑Hour Overview
- Current trading price: USD 6.27
- 24‑hour change: down 0.6 %
- Last closing price (11:58 PM Central Europe, Tuesday 20 Oct 2026): USD 6.27
- Shares outstanding: 63.5 million
- Market capitalization: USD 423.9 million
- Volume traded in last 24 hours: USD 850.6 k (approximately 135,700 shares)
- Monthly change (from end‑of‑month): down 16.92 %
- 200‑day simple moving average: USD 9.57
- 52‑week high: USD 14.85 (13 Jul 2026)
- 52‑week low: USD 6.08 (27 Jul 2026)
Related Stock Activity – Last 24 Hours
| Ticker | Company | 24‑hr change | Current price | Market cap (USD m) | Additional notes |
|---|---|---|---|---|---|
| FWRD | Forward Air | +1.86 % | USD 15.31 | 508.1 | – |
| WNC | Wabash National | –0.81 % | USD 12.73 | 503.5 | – |
| YORW | York Water | –1.91 % | USD 30.74 | 502.1 | 30‑year‑old CEO, VP‑Engineering, COO, CFO, President & CEO, and CAO & General Counsel filed Form 4 on 19 Oct 2026 indicating routine purchases of shares under the dividend‑reinvestment program; minor indirect holdings reported for the CEO’s child. No change in controlling interest. |
| MEI | Methode Electronics | +5.03 % | USD 14.15 | 501.0 | Perpetual Resources Limited announced a new resource‑definition drilling program for its Raptor Rare Earth Project in Brazil, aiming to map high‑grade Ionic Adsorption Clay mineralisation identified in previous shallow drilling. The programme will determine drilling methodology, spacing, budget, and timing before a final update. The decision follows increased interest in the Poços de Caldas district and recent corporate activity involving Lynas Rare Earths and Meteoric Resources. |
| CBIO | Crescent Biopharma | +4.39 % | USD 13.07 | 506.8 | Analyst coverage: HC Wainwright (buy, price target set), TD Cowen (strong‑buy), Wedbush (outperform). Weiss Ratings issued a sell recommendation earlier in the year. Earnings matched consensus; insiders executed modest sales under pre‑arranged plans. Institutional investors hold the majority of shares; a few hedge funds increased positions during the quarter. |
Summary
General Fusion’s stock experienced a modest decline of 0.6 % over the last 24 hours, trading at USD 6.27. The company’s market capitalization remains at USD 423.9 million, with a 200‑day simple moving average of USD 9.57. The 52‑week high and low indicate a recent range between USD 14.85 and USD 6.08.
In the same period, other firms in the portfolio showed mixed performance: Forward Air posted a small gain, Wabash National and York Water declined slightly, while Methode Electronics and Crescent Biopharma posted gains of 5.03 % and 4.39 % respectively. Notable corporate actions included routine share purchases by York Water executives under its dividend‑reinvestment program and the announcement of a new drilling program by Perpetual Resources Limited for a rare‑earth project in Brazil. Analyst sentiment for Crescent Biopharma remains largely positive despite a prior sell recommendation from Weiss Ratings.
